Literature DB >> 28512724

Congenital Pulmonary Alveolar Proteinosis: From Birth to Ten-years of Age.

Sandra Alavuk Kundović1, Ljiljana Popović2.   

Abstract

Pulmonary alveolar proteinosis is a rare lung disease in which lipoproteinaceous material accumulates within the alveoli, interfering with gas exchange. The disease is classified into congenital, secondary, and acquired. The congenital form includes inborn errors of surfactant metabolism, lysinuric protein intolerance and mutations in the components of granulocyte-macrophage colony-stimulating factor receptor. The main symptoms are non-specific. The radiologic appearance of pulmonary alveolar proteinosis is bilateral, symmetric and perihilar airspace consolidation. Bronchoalveolar lavage is crucial for diagnosis of the disease. There is only one ten-year-old patient with diagnosed congenital form in Croatia. What makes him different from other children in the world is that since the ninth month of his life he has been mechanically ventilated. Diagnosis of postnatal alveolar proteinosis should be considered in every infant with respiratory distress with diffuse alveolar and interstitial infiltrate.

Entities:  

Keywords:  Congenital alveolar proteinosis; Pulmonary lavage; Surfactant; Treatment

Mesh:

Year:  2017        PMID: 28512724     DOI: 10.1007/s12098-017-2365-6

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  7 in total

1.  GM-CSF therapy in pulmonary alveolar proteinosis.

Authors:  M G de Vega; A Sánchez-Palencia; A Ramírez; S Cervera; J Aneiros
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

Review 2.  Pulmonary alveolar proteinosis in children.

Authors:  Jacques de Blic
Journal:  Paediatr Respir Rev       Date:  2004-12       Impact factor: 2.726

3.  CT features of pulmonary alveolar proteinosis.

Authors:  J M Holbert; P Costello; W Li; R M Hoffman; R M Rogers
Journal:  AJR Am J Roentgenol       Date:  2001-05       Impact factor: 3.959

4.  Clinical, radiological and pathological features of ABCA3 mutations in children.

Authors:  M L Doan; R P Guillerman; M K Dishop; L M Nogee; C Langston; G B Mallory; M M Sockrider; L L Fan
Journal:  Thorax       Date:  2007-11-16       Impact factor: 9.139

Review 5.  Pulmonary alveolar proteinosis: progress in the first 44 years.

Authors:  John F Seymour; Jeffrey J Presneill
Journal:  Am J Respir Crit Care Med       Date:  2002-07-15       Impact factor: 21.405

6.  Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis.

Authors:  Jenna Hildebrandt; Ebru Yalcin; Hans-Georg Bresser; Guzin Cinel; Monika Gappa; Alireza Haghighi; Nural Kiper; Soheila Khalilzadeh; Karl Reiter; John Sayer; Nicolaus Schwerk; Anke Sibbersen; Sabine Van Daele; Georg Nübling; Peter Lohse; Matthias Griese
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

7.  Congenital pulmonary alveolar proteinosis.

Authors:  Saber Hammami; Khaled Harrathi; Khaled Lajmi; Samir Hadded; Chebil Ben Meriem; Mohamed Néji Guédiche
Journal:  Case Rep Pediatr       Date:  2013-04-27
  7 in total
  2 in total

Review 1.  Pulmonary Alveolar Proteinosis and Pregnancy: A Review of the Literature and Case Presentation.

Authors:  Brindusa Ana Cimpoca Raptis; Anca Maria Panaitescu; Gheorghe Peltecu; Nicolae Gica; Radu Botezatu; Mihaela Roxana Popescu; Anca Macri; Ana Constantin; Bogdan Pavel
Journal:  Medicina (Kaunas)       Date:  2022-07-23       Impact factor: 2.948

2.  Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim).

Authors:  Marta E Gajewska; Sajitha S Sritharan; Eric Santoni-Rugiu; Elisabeth M Bendstrup
Journal:  Respir Med Case Rep       Date:  2018-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.